CCH Pharmaceuticals Report issue

For profit Phase 2
Founded: Copenhagen Denmark (2019)
Status: No NME R&D (2019)

Organization Overview

First Clinical Trial
2019
NCT04179266
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

CCH Pharmaceuticals

Active Ingredients

Drugs in Phase 2 Trials (1)

ketamine (ketalar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cluster Headache (Phase 2)

Headache (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1